Apheresis Equipment Market to Register 8% CAGR, Surging from $2.89 Billion in 2024 to $4.95 Billion by 2031

United States of America – January 16, 2025 – According to The Insight Partners, The Apheresis Equipment Market is expected to register a CAGR of 8.00% from 2025 to 2031, with a market size expanding from US$ 2.89 Billion in 2024 to US$ 4.95 Billion by 2031. The apheresis equipment market continues to evolve rapidly, driven by advancements in medical technology and growing demand for targeted blood component therapies. Leading companies pioneer disposable kits and automated machines that enhance precision in procedures like plasmapheresis and leukapheresis.​

Get a Sample Copy At - https://www.theinsightpartners.com/sample/TIPHE100001288/

Market Overview and Drivers

Apheresis equipment enables the selective removal of specific blood components, making it essential for therapeutic interventions in hospitals and blood centers. Innovations in apheresis machines and disposable apheresis kits streamline operations while minimizing risks.

The apheresis equipment market benefits from rising awareness of personalized medicine and efficient blood processing needs. Procedures such as erythrocytapheresis, LDL-apheresis, photopheresis, plateletpheresis, and plasmapheresis address diverse therapeutic areas, from hematology to other applications.​

Key drivers include regulatory approvals for portable devices and expanded use in regenerative therapies. North America leads due to advanced healthcare infrastructure, while Asia-Pacific emerges as a high-growth region fueled by increasing healthcare investments.​

Latest Industry News

Recent developments underscore momentum in the apheresis equipment market. Terumo Corporation announced enhancements to its plasma collection systems, improving efficiency for high-volume centers.​

Fresenius Medical Care expanded its portfolio with next-generation apheresis equipment tailored for renal diseases, emphasizing user-friendly interfaces. Haemonetics Corporation reported successful trials of automated disposable kits, reducing contamination risks in plateletpheresis.​

B. Braun Melsungen AG introduced membrane separation upgrades, optimizing LDL-apheresis for cardiovascular care. Asahi Kasei Corporation launched portable units for neurology applications, gaining traction in outpatient settings.

Market leaders like Medica SPA and Kawasumi Laboratories continue to innovate, focusing on biocompatibility, ease of use, and integration with digital health platforms.​

Global and Regional Analysis

The apheresis equipment market exhibits strong global dynamics, with distinct regional variations. North America dominates, supported by robust reimbursement policies and high procedure volumes, particularly in plasmapheresis for autoimmune treatments.​

Europe sees steady expansion driven by EU regulations favoring centrifugation technology, with strong adoption in leukapheresis for oncology applications. Asia-Pacific represents the fastest-growing region, with rising healthcare access in India and China emphasizing affordable disposable kits.​

Latin America and the Middle East & Africa show emerging potential through international partnerships and training programs for photopheresis. Mature markets prioritize automation, while developing areas focus on cost-effective solutions.​

Market Size, Share, Trends, Analysis, and Forecast to 2031

Stakeholders in the apheresis equipment market anticipate sustained growth through 2031, propelled by technological integration and expanding indications. The market is projected to expand significantly from current valuations, reflecting demand for apheresis machines and kits.​

Market share remains dominated by centrifugation over membrane separation, with disposables gaining ground due to hygiene standards. Trends highlight a shift toward automation, portability, and AI-enhanced monitoring for real-time procedure adjustments.​

Analysis shows therapeutic areas like hematology leading, with neurology advancing through neuroinflammatory treatments; product segments favor machines for scalability. Plasmapheresis commands high volume, while photopheresis grows in niche autoimmune therapies.

Forecast to 2031 signals a robust trajectory, supported by regulatory approvals and stem cell therapy synergies, with Asia-Pacific contributing the highest incremental growth.​

Key Company Profiles and Innovations

Prominent players drive the apheresis equipment market through dedicated R&D and strategic alliances. Medica SPA excels in compact machines and disposable kits tailored for renal use.​

Terumo Corporation leads in plasma technology with automated collection systems. B. Braun Melsungen AG brings centrifugation expertise, including recent LDL-apheresis upgrades.

Fresenius Medical Care offers integrated solutions and portable renal devices. Asahi Kasei Corporation specializes in membrane filtration for neurology applications.​

Haemonetics Corporation focuses on hematology with plateletpheresis automation. HemaCare Corporation provides custom kits for research, while Kaneka Medix Corporation advances photopheresis for autoimmune therapies.​

Kawasumi Laboratories emphasizes affordable options for emerging market expansion. These firms collectively prioritize safety, efficacy, and broader accessibility.​

Purchasing This Report? Click Here At - https://www.theinsightpartners.com/buy/TIPHE100001288/

If you have any special requirements about this Apheresis Equipment Market report, please let us know and we can provide custom report.

Future Outlook

The apheresis equipment market stands at the forefront of therapeutic innovation, bridging blood science and precision medicine. Ongoing collaborations promise refined procedures and global reach.

Related Reports

• Leukapheresis Market Outlook and Strategic Insights by 2028
• Blood Transfusion Devices Market Growth, Size, Share, Trends, Key Players Analysis, and Forecast until 2031
• Plasmapheresis Machines Market Growth, Trends, and Forecast by 2034

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:

Contact Person: Ankit Mathur

Email: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in: 日本| 한국어 | French | لعربية< |中文| Italian | Spanish | German